QQ客服 官方微博 反馈留言

	Anti-tumor outcome evaluation against non-small cell lung cancer in vitro and in vivo using Polyl:C as nucleic acid therapeutic agent
	Wu, Yedan; Huang, Wei; Chen, Liqing; Jin, Mingji; Gao, Zhonggao; An, Changshan; Lin, Haixiang
	2019
卷号	11期号:4页码:1919-1937
关键词	TLR3 Polyl:C lung cancer immunotherapy PI3K/Akt/p53 cytokines DC
ISSN号	1943-8141
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6341312
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wu, Yedan,Huang, Wei,Chen, Liqing,et al. Anti-tumor outcome evaluation against non-small cell lung cancer in vitro and in vivo using Polyl:C as nucleic acid therapeutic agent[J],2019,11(4):1919-1937.
APA	Wu, Yedan.,Huang, Wei.,Chen, Liqing.,Jin, Mingji.,Gao, Zhonggao.,...&Lin, Haixiang.(2019).Anti-tumor outcome evaluation against non-small cell lung cancer in vitro and in vivo using Polyl:C as nucleic acid therapeutic agent.,11(4),1919-1937.
MLA	Wu, Yedan,et al."Anti-tumor outcome evaluation against non-small cell lung cancer in vitro and in vivo using Polyl:C as nucleic acid therapeutic agent".11.4(2019):1919-1937.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。